Repligen Corporation <RGEN.O>: UBS Raises Target Price to $225 From $195
RGEN•Related News
Twist Bioscience Corporation <TWST.O>: UBS initiates coverage with neutral rating and target price $144
TWST•
Nasdaq trade halt continues <MGN.O> volatility trading pause at 09:38 AM
MGN•
Heartflow, Inc. <HTFL.O>: UBS initiates coverage with neutral rating and target price $55
HTFL•
MicroVision Semiconductor wins government contractor project for custom photonics chip design
MVIS•
Trio Petroleum FY26 Q3 net loss widens 42.2% to $1.97 million; revenue climbs 81.2% to $348,581
TPET•